UNIGE document Scientific Article
previous document  unige:28146  next document
add to browser collection

Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation

Mhawech, P.
Benz, A.
Cerato, C.
Greloz, V.
Desmond, J. C.
Koeffler, H. P.
Lodygin, D.
show hidden authors show all authors [1 - 11]
Published in Modern pathology. 2005, vol. 18, no. 3, p. 340-348
Abstract The 14-3-3sigma inhibitor of cell cycle progression has been shown to be target of epigenetic deregulation in many forms of human cancers; however, its role in urological and gynecological cancers has not been studied. Here, we have analyzed the expression of 14-3-3sigma, wild-type p53 and mutated p53 in over 300 cases of the most common cancers occurring in the urological and gynecological tracts and its normal counterpart tissue by immunohistochemistry using the multiple tumor tissue microarrays. 14-3-3sigma expression was detected in normal epithelia from most organs with sporadic expression in renal tubules and absence in the testis. In contrast to normal tissue, 14-3-3sigma expression was lost in 40-60% of adenocarcinomas of the breast, ovary, endometrium and prostate. There was no association between 14-3-3sigma and wild-type/mutated p53 expression. By performing methylation-specific PCR, we showed a close association of 14-3-3sigma CpG island methylation and low protein expression levels of 14-3-3sigma. In addition, a direct link of 14-3-3sigma mRNA expression levels to CpG island methylation is demonstrated in two human cancer cell lines. Loss of 14-3-3sigma expression due to promoter hypermethylation may represent the most frequent molecular aberration in ovarian, endometrial and prostate adenocarcinomas.
Keywords Azacitidine/pharmacologyCell Line, TumorComparative StudyCpG Islands/*genetics*DNA MethylationDown-RegulationEndometrial Neoplasms/genetics/metabolism/pathologyExonucleases/biosynthesis/*geneticsFemaleGene Expression Regulation, Neoplastic/drug effectsHumansImmunohistochemistryMaleMutationNeoplasm Proteins/biosynthesis/*geneticsNeoplasms/*genetics/metabolism/pathologyOvarian Neoplasms/genetics/metabolism/pathologyProstatic Neoplasms/genetics/metabolism/pathologyProtein p53/geneticsRNA, Messenger/genetics/metabolismResearch Support, Non-U.S. Gov'tTissue Array AnalysisTumor Markers, Biological/biosynthesis/*genetics
PMID: 15257317
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
MHAWECH, P. et al. Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation. In: Modern pathology, 2005, vol. 18, n° 3, p. 340-348. https://archive-ouverte.unige.ch/unige:28146

422 hits

0 download


Deposited on : 2013-05-28

Export document
Format :
Citation style :